理解骨质疏松性疼痛及其药物治疗:补充说明
本文阐述骨质疏松性骨折可致急性与慢性伤害性及神经病理性疼痛,中枢敏化似在骨折后疼痛慢性化中起关键作用;抗骨质疏松药可部分控制疼痛,但骨折疼痛常需额外镇痛药;慢性疼痛需药物与非药物多模式阶梯治疗。
要点
- 抗骨质疏松药物能部分控制疼痛,但骨折所致疼痛始终需要额外镇痛药。
- 非甾体抗炎药和选择性COX-2抑制剂可减轻急性疼痛,但对慢性神经病理性疼痛成分效果差且有相关副作用。
- 阿片类药物可控制急性与慢性骨痛全谱,但在神经病理性成分疗效、耐受性和安全性方面存在差异。
核心结论
- 骨质疏松性骨折后慢性疼痛需要多模式方法,包括抗骨质疏松治疗、对乙酰氨基酚、非甾体抗炎药、选择性COX-2抑制剂、弱阿片和强阿片类药物及非药物治疗。
- 基于对骨质疏松性和骨折后疼痛发病机制的更好理解,对骨折后骨质疏松性疼痛采用有指导的阶梯式方法将更好地满足这些患者的需求。
研究设计与样本
- 本文为补充说明性文章,原文未报告系统检索范围或研究设计细节。
主要发现
- 中枢敏化似乎在骨质疏松性骨折后疼痛的慢性化发展中起关键作用。
- 非甾体抗炎药和选择性COX-2抑制剂可减轻急性疼痛,但对慢性神经病理性疼痛成分效果差,且有相关副作用。
- 阿片类药物可控制急性与慢性骨痛全谱,但在神经病理性成分疗效、耐受性和安全性方面存在差异。
临床怎么用
- 抗骨质疏松药物能部分控制疼痛,但骨折所致疼痛始终需要额外镇痛药。
- 骨折后慢性疼痛需要多模式方法,包括抗骨质疏松治疗、对乙酰氨基酚、非甾体抗炎药、选择性COX-2抑制剂、弱阿片和强阿片类药物及非药物治疗。
- 基于对疼痛发病机制的更好理解,作者提出对骨折后骨质疏松性疼痛采用有指导的阶梯式方法。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Osteoporosis, a disorder that affects millions of people worldwide, is characterized by decreased bone mass and microstructural alterations giving rise to an increased risk of fractures. Osteoporotic fractures can cause acute and chronic nociceptive and neuropathic pain that mainly affects elderly patients with multiple comorbidities and commonly on different drug regimens. Central sensitization seems to play a pivotal role in developing and maintaining chronicity of post-fracture pain in osteoporosis. Antiosteoporosis drugs are able to partially control pain, but additional analgesics are always necessary for pain due to bone fractures. Nonsteroidal anti-inflammatory drugs (NSAIDs) and selective COX-2 inhibitors reduce acute pain but with a poor effect on the chronic neuropathic component of pain and with relevant side effects. Opioid drugs can control the whole spectrum of acute and chronic bone pain, but they differ with respect to their efficacy on neuropathic components, their tolerability and safety. Chronic pain after osteoporotic fractures requires a multifaceted approach, which includes a large spectrum of drugs (antiosteoporosis treatment, acetaminophen, NSAIDs, selective COX-2 inhibitors, weak and strong opioids) and non-pharmacological treatment. Based on a better understanding of the pathogenesis of osteoporotic and post-fracture pain, a guided stepwise approach to post-fracture osteoporotic pain will also better meet the needs of these patients.
引用
- Vellucci R, Terenzi R, Kanis JA, et al. Understanding osteoporotic pain and its pharmacological treatment: supplementary presentation. Osteoporos Int. 2018. PMID: 29992509. doi:10.1007/s00198-018-4536-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。